… NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), an innovative biopharmaceutical company engaged in the discovery … proceeds from borrowings, representing receipts from our Innovation credit grant. As of September 30, 2014, we held … after market authorization. About ProQR ProQR is an innovative biopharmaceutical company engaged in the discovery …
Post-hoc analyses from Illuminate trial of sepofarsen demonstrate an encouraging efficacy signal when comparing active treatment and sham eyes to their corresponding contralateral eyes across multiple endpoints – Company plans to discuss findings with regulators and pr